Item 8.01. Other Events.

On January 5, 2021, Cerecor Inc. (the "Company") issued a press release announcing top line data from its proof-of-concept clinical trial of CERC-002 in patients with COVID-19 induced Acute Respiratory Distress Syndrome ("ARDS"). On January 5, 2021, the Company also posted on its website an informational presentation regarding this top line data. Copies of the press release and informational presentation are attached hereto as Exhibits 99.1 and 99.2, respectively, and are incorporated herein in their entirety by reference.

Item 9.01. Financial Statements and Exhibits.



(d)  Exhibits.
              Exhibit No.                      Description

                  99.1           Press Release dated January 5, 2021.

                  99.2           Informational Presentation.



                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses